140 related articles for article (PubMed ID: 16601144)
1. Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma.
Cuzzocrea S; Genovese T; Mazzon E; Crisafulli C; Di Paola R; Muià C; Collin M; Esposito E; Bramanti P; Thiemermann C
J Pharmacol Exp Ther; 2006 Jul; 318(1):79-89. PubMed ID: 16601144
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury.
Genovese T; Mazzon E; Crisafulli C; Di Paola R; Muià C; Bramanti P; Cuzzocrea S
J Pharmacol Exp Ther; 2006 Mar; 316(3):1006-16. PubMed ID: 16303916
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the role of mitogen-activated protein kinase signaling pathways in the development of spinal cord injury.
Genovese T; Esposito E; Mazzon E; Muià C; Di Paola R; Meli R; Bramanti P; Cuzzocrea S
J Pharmacol Exp Ther; 2008 Apr; 325(1):100-14. PubMed ID: 18180375
[TBL] [Abstract][Full Text] [Related]
4. Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Crisafulli C; Esposito E; Di Paola R; Muià C; Di Bella P; Meli R; Bramanti P; Cuzzocrea S
Neuroscience; 2007 Nov; 150(1):168-81. PubMed ID: 17945432
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tyrosine kinase-mediated cellular signalling by Tyrphostins AG126 and AG556 modulates secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Esposito E; Muià C; Di Paola R; Crisafulli C; Bramanti P; Cuzzocrea S
Neuropharmacology; 2007 Jun; 52(7):1454-71. PubMed ID: 17418876
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3beta inhibition attenuates the development of bleomycin-induced lung injury.
Cuzzocrea S; Genovese T; Mazzon E; Esposito E; Muià C; Abdelrahman M; Di Paola R; Bramanti P; Thiemermann C
Int J Immunopathol Pharmacol; 2007; 20(3):619-30. PubMed ID: 17880775
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase 3beta inhibition reduces the development of nonseptic shock induced by zymosan in mice.
Cuzzocrea S; Di Paola R; Mazzon E; Crisafulli C; Genovese T; Muià C; Abdelrahman M; Esposito E; Thiemermann C
Shock; 2007 Jan; 27(1):97-107. PubMed ID: 17172987
[TBL] [Abstract][Full Text] [Related]
8. Glycyrrhizin reduces secondary inflammatory process after spinal cord compression injury in mice.
Genovese T; Menegazzi M; Mazzon E; Crisafulli C; Di Paola R; Dal Bosco M; Zou Z; Suzuki H; Cuzzocrea S
Shock; 2009 Apr; 31(4):367-75. PubMed ID: 18665052
[TBL] [Abstract][Full Text] [Related]
9. N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone reduces severity of experimental spinal cord injury.
Genovese T; Mazzon E; Esposito E; Muià C; Di Paola R; Crisafulli C; Bramanti P; Cuzzocrea S
Shock; 2007 Mar; 27(3):258-65. PubMed ID: 17304106
[TBL] [Abstract][Full Text] [Related]
10. Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin.
Genovese T; Mazzon E; Muià C; Bramanti P; De Sarro A; Cuzzocrea S
J Pineal Res; 2005 Apr; 38(3):198-208. PubMed ID: 15725342
[TBL] [Abstract][Full Text] [Related]
11. Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus.
Collino M; Thiemermann C; Mastrocola R; Gallicchio M; Benetti E; Miglio G; Castiglia S; Danni O; Murch O; Dianzani C; Aragno M; Fantozzi R
Shock; 2008 Sep; 30(3):299-307. PubMed ID: 18323734
[TBL] [Abstract][Full Text] [Related]
12. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
Genovese T; Esposito E; Mazzon E; Di Paola R; Muià C; Meli R; Bramanti P; Cuzzocrea S
Shock; 2008 Aug; 30(2):142-52. PubMed ID: 18628687
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Muià C; Patel NS; Threadgill MD; Bramanti P; De Sarro A; Thiemermann C; Cuzzocrea S
J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the role of peroxisome proliferator-activated receptor-beta/delta in the development of spinal cord injury.
Paterniti I; Esposito E; Mazzon E; Galuppo M; Di Paola R; Bramanti P; Kapoor A; Thiemermann C; Cuzzocrea S
J Pharmacol Exp Ther; 2010 May; 333(2):465-77. PubMed ID: 20176685
[TBL] [Abstract][Full Text] [Related]
15. Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury.
Genovese T; Esposito E; Mazzon E; Di Paola R; Meli R; Bramanti P; Piomelli D; Calignano A; Cuzzocrea S
J Pharmacol Exp Ther; 2008 Jul; 326(1):12-23. PubMed ID: 18367664
[TBL] [Abstract][Full Text] [Related]
16. Effect of 17beta-estradiol on signal transduction pathways and secondary damage in experimental spinal cord trauma.
Cuzzocrea S; Genovese T; Mazzon E; Esposito E; Di Paola R; Muià C; Crisafulli C; Peli A; Bramanti P; Chaudry IH
Shock; 2008 Mar; 29(3):362-71. PubMed ID: 17704735
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in mice.
Cuzzocrea S; Crisafulli C; Mazzon E; Esposito E; Muià C; Abdelrahman M; Di Paola R; Thiemermann C
Br J Pharmacol; 2006 Nov; 149(6):687-702. PubMed ID: 17016509
[TBL] [Abstract][Full Text] [Related]
18. Effects of glycogen synthase kinase-3beta inhibition on the development of cerulein-induced acute pancreatitis in mice.
Cuzzocrea S; Malleo G; Genovese T; Mazzon E; Esposito E; Muià C; Abdelrahman M; Di Paola R; Thiemermann C
Crit Care Med; 2007 Dec; 35(12):2811-21. PubMed ID: 18074481
[TBL] [Abstract][Full Text] [Related]
19. Effect of fasudil, a selective inhibitor of Rho kinase activity, in the secondary injury associated with the experimental model of spinal cord trauma.
Impellizzeri D; Mazzon E; Paterniti I; Esposito E; Cuzzocrea S
J Pharmacol Exp Ther; 2012 Oct; 343(1):21-33. PubMed ID: 22733360
[TBL] [Abstract][Full Text] [Related]
20. Modulation of inflammatory response after spinal cord trauma with deferoxamine, an iron chelator.
Paterniti I; Mazzon E; Emanuela E; Paola RD; Galuppo M; Bramanti P; Cuzzocrea S
Free Radic Res; 2010 Jun; 44(6):694-709. PubMed ID: 20370565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
